Latest Advanced Materials And Life Sciences News

AnteoTech expects to increase its unaudited FY2026 loss to $5.38 million after revising the accounting treatment of a lease make-good provision. The adjustment is non-cash, leaving cash and cash flows unchanged, but the audit is still incomplete and the figures may change again.

AnteoTech has raised A$3.5 million through a discounted share placement to accelerate commercialisation of its advanced battery and life sciences technologies globally. The capital injection supports strategic partnerships and sales expansion in key markets including the US and India.